Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $128,797 | $26,135 | $13,888 | $75,762 |
| - Cash | $17,198 | $13,724 | $17,003 | $25,007 |
| + Debt | $3,239 | $20,884 | $25,090 | $26,591 |
| Enterprise Value | $114,838 | $33,296 | $21,975 | $77,346 |
| Revenue | $0 | $0 | $0 | $882 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$600 | $0 | -$1,488 | -$758 |
| % Margin | – | – | – | -85.9% |
| EBITDA | -$37,737 | -$40,105 | -$38,727 | -$54,350 |
| % Margin | – | – | – | -6,164.2% |
| Net Income | -$40,209 | -$44,604 | -$55,833 | -$45,553 |
| % Margin | – | – | – | -5,166.4% |
| EPS Diluted | -3.68 | -10.31 | -10.15 | -11.11 |
| % Growth | 64.3% | -1.6% | 8.6% | – |
| Operating Cash Flow | -$41,794 | -$36,100 | -$37,544 | -$48,184 |
| Capital Expenditures | $0 | $0 | -$13 | -$54 |
| Free Cash Flow | -$41,794 | -$36,100 | -$37,558 | -$48,238 |